NEOGENOMICS INC (NEO) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001077183 · SEC filings checked Oct 17, 2026
Next report
Oct 27, 2026
Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$17.25
Polygon.io daily close, Oct 15, 2026. End of day, not live.
Trailing diluted EPS
—
Needs four consecutive reported quarters.
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $201.7M | $2.2M | — | Filing |
| Mar 31, 2026 | Apr 28, 2026 | $186.7M | $-17.1M | — | Filing |
| Dec 31, 2025 | Jan 12, 2026 | $190.2M | $-9.9M | — | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $187.8M | $-27.1M | — | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $181.3M | $-45.1M | — | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $168.0M | $-25.9M | — | Filing |
| Dec 31, 2024 | Feb 18, 2025 | $172.0M | $-15.6M | — | Filing |
| Sep 30, 2024 | Nov 5, 2024 | $167.8M | $-17.7M | — | Filing |
What would NEOGENOMICS INC have to report for its valuation to change?
Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.